Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

Encouraging generic use can yield significant savings.

Zimmerman C.

Find Brief. 2012 Nov;15(8):1-3.

PMID:
23213854
[PubMed - indexed for MEDLINE]
2.

In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.

Hoadley JF, Merrell K, Hargrave E, Summer L.

Health Aff (Millwood). 2012 Oct;31(10):2266-75. doi: 10.1377/hlthaff.2012.0019.

PMID:
23048108
[PubMed - indexed for MEDLINE]
3.

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.

Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.

J Manag Care Pharm. 2014 Mar;20(3):283-90.

PMID:
24564812
[PubMed - indexed for MEDLINE]
Free Article
4.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
[PubMed - indexed for MEDLINE]
5.

Zero copayment for generic statins could save billions.

[No authors listed]

Manag Care. 2013 Mar;22(3):44. No abstract available.

PMID:
23610806
[PubMed - indexed for MEDLINE]
Free Article
6.

Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.

Bazalo G, Weiss RC.

Consult Pharm. 2012 Apr;27(4):269-73. doi: 10.4140/TCP.n.2012.269.

PMID:
22498986
[PubMed - indexed for MEDLINE]
7.

Generic script share and the price of brand-name drugs: the role of consumer choice.

Rizzo JA, Zeckhauser R.

Int J Health Care Finance Econ. 2009 Sep;9(3):291-316. doi: 10.1007/s10754-008-9052-0. Epub 2009 Jan 8.

PMID:
19130220
[PubMed - indexed for MEDLINE]
8.

Impact of medicare part D plan features on use of generic drugs.

Tang Y, Gellad WF, Men A, Donohue JM.

Med Care. 2014 Jun;52(6):541-8. doi: 10.1097/MLR.0000000000000142.

PMID:
24824538
[PubMed - indexed for MEDLINE]
9.

Private expenditures on brand name prescription drugs after generic entry.

Balaban DY, Dhalla IA, Law MR, Bell CM.

Appl Health Econ Health Policy. 2013 Oct;11(5):523-9. doi: 10.1007/s40258-013-0052-y.

PMID:
23979876
[PubMed - indexed for MEDLINE]
10.

Comparison of prescription drug costs in the United States and the United Kingdom, Part 1: statins.

Jick H, Wilson A, Wiggins P, Chamberlin DP.

Pharmacotherapy. 2012 Jan;32(1):1-6. doi: 10.1002/PHAR.1005.

PMID:
22392823
[PubMed - indexed for MEDLINE]
11.

Free statins disrupt pharmacy benefit plans.

Reinke T.

Manag Care. 2012 Nov;21(11):19-20. No abstract available.

PMID:
23236713
[PubMed - indexed for MEDLINE]
Free Article
12.

Measuring economic impact of applying daily average consumption limits.

Flavin BM, Nishida LM, Karbowicz SH, Renner ME, Leonard RJ.

J Manag Care Pharm. 2014 Feb;20(2):159-64.

PMID:
24456317
[PubMed - indexed for MEDLINE]
Free Article
13.

Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.

Tran YB, Frial T, Miller PS.

Can J Clin Pharmacol. 2007 Summer;14(2):e205-14. Epub 2007 Jun 5.

PMID:
17556788
[PubMed - indexed for MEDLINE]
Free Article
14.

The effects of copayments and generic substitution on the use and costs of prescription drugs.

Smith DG.

Inquiry. 1993 Summer;30(2):189-98.

PMID:
8314607
[PubMed - indexed for MEDLINE]
15.
16.

Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.

Bishop CE, Ryan AM, Gilden DM, Kubisiak J, Thomas CP.

Health Serv Res. 2009 Jun;44(3):1010-28. doi: 10.1111/j.1475-6773.2009.00951.x. Epub 2009 Mar 2.

PMID:
19291168
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pattern of statins' utilization at Ramathobodi Hospital, 2005 to 2007.

Pattanaprateep O, Pongcharoensuk P, Suvanakoot P, Kaojarern S.

J Med Assoc Thai. 2010 Oct;93(10):1223-31.

PMID:
20973328
[PubMed - indexed for MEDLINE]
18.

Prescription drug costs and the generic dispensing ratio.

Liberman JN, Roebuck MC.

J Manag Care Pharm. 2010 Sep;16(7):502-6.

PMID:
20726679
[PubMed - indexed for MEDLINE]
Free Article
19.

Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.

Zhang S, Doucette WR, Urmie JM, Xie Y, Brooks JM.

Res Social Adm Pharm. 2010 Jun;6(2):121-9. doi: 10.1016/j.sapharm.2010.03.004. Epub 2010 May 7.

PMID:
20511111
[PubMed - indexed for MEDLINE]
20.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

PMID:
14657430
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk